Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Kuhlmann

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cells|June 28, 2023
The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAPJulia Fleischmann, Laura S Hildebrand, Lukas Kuhlmann, et al.
International Journal of Molecular Sciences|June 19, 2024
Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and NiraparibJacob Mentzel, Laura S Hildebrand, Lukas Kuhlmann, et al.
Discover Oncology|October 4, 2024
Radiosensitivity in individuals with tuberous sclerosis complexLukas Kuhlmann, Jenny Stritzelberger, Rainer Fietkau, et al.
International Journal of Molecular Sciences|February 24, 2024
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, et al.
Cells|March 11, 2023
Increased Radiation Sensitivity in Patients with Phelan-McDermid SyndromeSarah Jesse, Lukas Kuhlmann, Laura S Hildebrand, et al.
Cells|April 25, 2025
Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus ErythematosusHannah Schenker, Lukas Kuhlmann, Dorothee Kaudewitz, et al.
Current Issues in Molecular Biology|August 25, 2023
Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes <i>BReast CAncer 1</i> and <i>BReast CAncer 2</i>Tara Zuhair Kassem, Marius Wunderle, Lukas Kuhlmann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cells|June 28, 2023
The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAPJulia Fleischmann, Laura S Hildebrand, Lukas Kuhlmann, et al.
International Journal of Molecular Sciences|June 19, 2024
Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and NiraparibJacob Mentzel, Laura S Hildebrand, Lukas Kuhlmann, et al.
Discover Oncology|October 4, 2024
Radiosensitivity in individuals with tuberous sclerosis complexLukas Kuhlmann, Jenny Stritzelberger, Rainer Fietkau, et al.
International Journal of Molecular Sciences|February 24, 2024
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, et al.
Cells|March 11, 2023
Increased Radiation Sensitivity in Patients with Phelan-McDermid SyndromeSarah Jesse, Lukas Kuhlmann, Laura S Hildebrand, et al.
Cells|April 25, 2025
Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus ErythematosusHannah Schenker, Lukas Kuhlmann, Dorothee Kaudewitz, et al.
Current Issues in Molecular Biology|August 25, 2023
Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes <i>BReast CAncer 1</i> and <i>BReast CAncer 2</i>Tara Zuhair Kassem, Marius Wunderle, Lukas Kuhlmann, et al.
Pageof 1